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Abstract
Background:  Gene identification by nonsense-mediated mRNA decay inhibition (GINI) has
proven its usefulness in identifying mutant genes in cancer cell lines. An increase in transcription in
response to NMD inhibition of a subset of genes is a major cause of false positives when genes are
selected for sequencing analysis. To distinguish between mRNA accumulations caused by stress
response-induced transcription and nonsense-containing mRNA stabilizations is a challenge in
identifying mutant genes using GINI.
Methods: To identify potential tumor-suppressor genes mutated in prostate cancer cell lines, we
applied a version of GINI that involves inhibition of NMD in two steps. In the first step, NMD is
inhibited in duplicate tissue-culture plates. During this step, both the substrate for NMD and stress-
response mRNA transcripts are accumulated in cells. In the second step, transcription is inhibited
in both plates and NMD is inhibited in one plate and released in the second plate. Microarray
analysis of gene-expression profiles in both plates after the second step detects only the differences
in mRNA degradation but not in mRNA accumulation.
Results: Analyzing gene expression profile alterations in 22RV1 and LNCaP prostate cancer cells
following NMD inhibition we selected candidates for sequencing analysis in both cell lines.
Sequencing identified inactivating mutations in both alleles of the PARD3 and AS3 genes in the
LNCaP and 22RV1 cells, respectively. Introduction of a wild-type PARD3 cDNA into the LNCaP
cells resulted in a higher proliferation rate in tissue culture, a higher adhesion of LNCaP cells to the
components of extracellular matrix and impaired the growth of the LNCaP cells in soft agar and in
a three-dimensional cell-culture.
Conclusion: The mutational inactivation in a prostate cancer cell line of the PARD3 gene involved
in asymmetric cell division and maintenance of cell-polarity suggests that the loss of cell-polarity
contributes to prostate carcinogenesis.
Published: 8 September 2009
BMC Cancer 2009, 9:318 doi:10.1186/1471-2407-9-318
Received: 20 March 2009
Accepted: 8 September 2009
This article is available from: http://www.biomedcentral.com/1471-2407/9/318
© 2009 Kunnev et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
Page 2 of 12
(page number not for citation purposes)
Background
Inactivation of tumor-suppressor genes in cancer cells fre-
quently occurs through the nonsense mutation in one
allele and the loss of the chromosome locus containing
the wild type allele. Identifying the nonsense mutations in
the remaining allele in regions of frequent losses of heter-
ozygosity in tumors indicates putative tumor suppressor
genes. Nonsense mutations located in mRNA sequences
more than 22 nucleotides upstream of the last exon/exon
junction elicit a rapid degradation of mutant mRNA
through the nonsense-mediated mRNA decay (NMD)
pathway [1,2]. Since triggering the NMD of mutant mRNA
requires an initial round of translation, blocking transla-
tion with specific drugs, such as emetine, has been shown
to abrogate the NMD-mediated degradation of mutant
mRNAs [3]. This results in an increased amount of mRNA
transcripts from genes containing nonsense or frameshift
mutations, which can be detected using gene-expression
microarrays. A strategy has been proposed for the identifi-
cation of genes containing nonsense or frameshift muta-
tions [4] using microarray analysis of mRNA profile
alterations resulting from inhibiting NMD in cell lines
(GINI).
The major complication in identifying mutant genes using
GINI is the fact that too many genes that do not contain
nonsense mutations show mRNA accumulation follow-
ing the blocking of NMD with emetine or small interfer-
ing RNA against hUpf1 and hUpf2 genes, the major
regulators of NMD. Part of these false-positive candidates
is represented by genes transcriptionally induced by stress
response to inhibition of NMD and the other part is rep-
resented by a natural substrate for NMD genes. These are
the genes that have an upstream open reading frame in
their 5' untranslated region, introns in the 3' untranslated
region and the products of alternative splicing that pro-
duce nonsense codons or frameshifts [5]. Using control
cell lines helps to eliminate false-positives represented by
the natural substrate of NMD genes but, due to the varia-
bility in stress response between different cancer cell lines,
does not efficiently eliminate false-positive candidates
produced by stress response. Combining GINI microarray
analysis with array-based comparative genomic hybridiza-
tion (aCGH) has been proposed for the genome-wide
identification of genes with biallelic inactivation involv-
ing nonsense mutations and loss of the wild-type allele.
Although this approach led to identification of a previ-
ously unknown mutation in the receptor tyrosine kinase
gene EPHB2 in the DU145 prostate cancer cell line [6],
combining GINI and aCGH is not the best strategy for
prostate cancer cells. The majority of prostate cancer cell
lines are known to have microsatellite instability (MSI),
which is caused by the inactivation of components of
DNA mismatch repair (MMR) in prostate cells [7]. Inacti-
vation of MMR causes a high rate of replication errors
resulting in an elevated frequency of mutations. An
inverse correlation between MSI and LOH reported for
colorectal cancer [8] suggests that in cancers with MSI the
inactivation of a tumor-suppressor gene is more likely to
occur by two independent mutations in two alleles rather
than by mutation in one allele and the loss of the other.
Of five cell lines the most frequently used for prostate can-
cer research experiments PC-3, LNCaP, DU-145, LAPC-4,
and 22RV1 only PC-3 does not have microsatellite insta-
bility. Therefore, relying upon aCGH analysis when
choosing candidates for sequencing out of list of genes
generated by GINI analysis of MSI positive prostate cancer
cell lines will result in missing genes inactivated by two
independent mutations.
In our lab, we have developed a modification of GINI that
allows us to eliminate from further analysis the candidate
genes that show mRNA increases due to stress response-
induced transcription [9]. The idea behind the modifica-
tion is use microarray analysis to measure only mRNA
degradation rather than the sum of two processes, mRNA
degradation and mRNA accumulation, caused either by
mutant mRNA stabilization or by the increased transcrip-
tion of stress-induced genes. In this work, we applied our
method to LNCaP and 22RV1 prostate cancer cell lines
with MSI, and identified previously unknown biallelic
inactivating mutations in the par-3 partitioning defective
3 homolog (PARD3) gene in LNCaP cells and the andro-
gen-induced prostate proliferative shutoff associated pro-
tein (AS3) gene in 22Rv1 cells.
Methods
Cell culture
The LNCaP and 22Rv1 prostate carcinoma cell lines
(ATCC) were grown in RPMI-1640 supplemented with
10% fetal bovine serum (FBS), 100 U/ml penicillin and
0.1 mg/ml.
GINI analysis
Cells were seeded in four tissue-culture plates. Caffeine
(10 mM) was added to three plates and one plate was
incubated without caffeine as a control. Following four
hours' incubation, the medium was removed from one
plate (with caffeine) and from the control plate and total
RNA was prepared using TRIZOL reagent, according to
manufacturer's instructions, and used for an Affymetrix
U133Plus2.0 oligonucleotide array hybridization. The
caffeine-containing medium of the two remaining plates
was removed, the cells were washed twice with phos-
phate-buffered saline and the medium with actinomycin
D (2 μg/ml) together with caffeine (10 mM) was added to
one plate. Actinomycin D alone was added to the other
plate. Following another four hours' incubation, the total
RNA from both plates was prepared and used for an
Affymetrix U133Plus2.0 oligonucleotide array analysis.BMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
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Affymetrix oligonucleotide array data analysis
Messenger RNA levels in drug-treated and untreated cells
were measured using the Affymetrix U133Plus2.0 array.
The results of array hybridization presented as CEL files
were imported into the Bioconductor system using the R
software package. Convolution background correction,
quantile normalization and a summarization of probe
intensity were processed using an adaptation of the
Robust Multi-Chip Average (gcRMA) [10]. To compute
GCRMA expression values, we conducted a gcrma func-
tion of the Bioconductor package, publicly available at the
http://www.bioconductor.org. The quantile normalized
log transformed GCRMA values were than used to select
candidate targets for sequencing analysis using selection
criteria described in the "Result" section of the text. The
Affymetrix gene expression data were submitted to Gene
Expression Omnibus (GEO) database under accession
number GSE16856.
Array comparative genomic hybridization
Genomic pooled normal control DNA and DNA from
LNCaP or from 22Rv1 cells were fluorescently labeled by
random priming and were hybridized to RPCI arrays con-
taining ~6,000 RPCI-11 BAC clones, as described [11].
The hybridized slides were scanned using a Genepix
4200A scanner (Axon, Inc., Union City, CA) to generate
high-resolution (10 μm) images for both Cy3 and Cy5
channels, and image analysis was performed using
ImaGene (version 4.1) software (BioDiscovery, Inc., El
Segundo, CA).
Sequencing analysis
One microgram of total RNA from caffeine-treated pros-
tate cancer cells was reverse transcribed using the Super-
Script II protocol (Invitrogen, Carlsbad, CA, USA).
Overlapping PCR primer sets were used to generate prod-
ucts spanning the entire open reading frames for candi-
date genes. Primers for sequencing analysis were designed
using Primer3 software available online http://
frodo.wi.mit.edu/primer3/. The PCR products were gel-
purified and sequenced using the Applied Biosystems'
PRISM 3100 Genetic Analyzer.
Cloning and expression of PARD3
Reverse transcribed RNA from MCF-10A cells (ATCC) was
used to amplify PARD3 cDNA by PCR with AccuPrime Pfx
DNA Polymerase (Invitrogen) with the following primer
sequences: Forward-gccaccATGAAAGTGACCGTGTGCT-
TCG; Reverse-TCACTTATCGTCGTCATCCTTGTAATCTCT
CTTCTCGGGCTTCAGTTTGGC. The primers were
designed with additional flanking sequences for Kozak
(for the forward primer) and the FLAG-tag sequence fol-
lowed by stop codon (for the reverse primer). The product
was cloned in a pCR-Blunt II TOPO (Invitrogen) vector by
using the Zero Blunt TOPO PCR Cloning Kit (Invitrogen).
The sequence and direction of the insert was verified by
sequencing. The PARD3 cDNA with Kozak and Flag-tag
sequences attached was sub-cloned into a pBMN-I-GFP
retroviral vector (a gift from Dr. G.Nolan from Stanford
University), at the EcoRI site.
The pBMN-I-GFP-PARD3-FLAG construct was used for
retroviral production according to the protocol described
in the manual available at http://www.addgene.org/
Garry_Nolan, based on the packaging cell line Phoenix
(authorized for Roswell Park Cancer Institute). The same
procedure was applied to the pBMN-I-GFP control vector
without an insert. The virus containing medium was col-
lected, filtrated with 0.4 μm Super Membrane Syringe Fil-
ter (Pall Corporation), concentrated by VIVASPIN 20 with
membrane 50,000 MWCO PES (sartorius sedim biotech)
and used for infection of the LNCaP cells. A week later the
cell was subjected to GFP cell-sorting with FACS. The Par3
protein expression was confirmed by immunoblotting
with an anti-FLAG mouse monoclonal antibody (Sigma)
as well as with anti-Par3 mouse polyclonal antibody
(Abcam).
Fluorescence microscopy
Cells were grown in a medium containing 10% FBS on
glass coverslips (22 mm × 22 mm). The cells was washed
with PBS and fixed with 4% paraformaldehyde, permeabi-
lized with 0.05% Triton X-100 for 10 min and blocked
with 3% milk in PBS for 30 min. The anti-Flag antibody
was added for one hour at a dilution of 1:300. A second
antibody, goat anti-mouse Alexa Fluor 568 (Texas Red),
was incubated for one hour at a dilution of 1:500. All
incubations were done at room temperature. Fluorescent
images were captured using a Nikon TE2000-E inverted
microscope equipped with Roper CoolSnap HQ CCD
camera.
Western blotting
The whole-cell lysates from cultured cells were prepared
with RIPA lysis buffer (50 mM Tris.HCl, pH 8.0, 150 mM
NaCl, 1% Igepal CA 630, 0.5% sodium deoxycholate,
0.1% SDS) supplemented with a protease inhibitor cock-
tail and phosphatase inhibitor cocktails I and II (Sigma).
The samples were sheared by 5-10 passes through a 27 g
needle incubated on ice for 40 min. Extracts were cleared
by centrifugation (30 min, 10,000 g, 4°C). Protein con-
centrations were determined by Bicinchoninic acid (BCA)
protein assay reagent (Pierce) and lysates were boiled in a
Laemmli samples buffer for 5 min before being subjected
to SDS-PAGE. Equal amounts of proteins were separated
using 10% SDS-polyacrylamide mini-gels. The proteins
were transferred to the nitrocellulose membrane and
stained with 0.1% Fast Green (Sigma) to confirm equal
loading and even transfer. Membranes were incubated
overnight with primary antibodies against Flag-tag (FBMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
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1804, mouse monoclonal M2, 1:1000, Sigma), anti-Par3
(Abcam, ab21987) or actin (A2066, rabbit polyclonal,
1:5000, Sigma), followed by incubation with respective
horseradish peroxidase-conjugated secondary antibodies
(sheep anti-mouse, 1:2000, Amersham). Immune com-
plexes were visualized using the Super Signal chemilumi-
nescence system (Pierce) and CL-XPosure film (Pierce).
Cell proliferation assay
5 × 103 cells per well were plated in a 24-well format tissue
culture plate in RPMI 1640 containing 5% fetal calf serum
(FBS). Cells were cultured for the indicated time periods,
trypsinized and counted by haemocytometer. The cell
number was shown as the average ± S.D. of counting four
individual wells per time-point. The experiment was
repeated independently three times with similar results.
Cell adhesion assay
The 96-well plates were pre-coated with 10 μg/ml (100 μl)
fibronectin (Sigma) or type I collagen (Calbiochem) in
PBS. Wells were blocked with 10 mg/ml BSA in PBS and
washed with PBS. Cells were seeded to the wells at 2 × 104/
well in a tissue-culture medium. The plate was incubated
for three hours in a CO2 incubator at 37°C. Nonadherent
and loosely attached cells were removed from the wells by
gently washing them with DPBS (Cellgro) and the
attached cells were fixed with 5% glutaraldehyde (E.M.S.).
Attached cells were counted by microscope at 200× mag-
nification.
Colony formation in soft agar assay
To assess the anchorage-independent growth of cells in
soft agar, 5 × 103 cells were suspended in 2 ml of 0.4%
L.M.P. agarose (Ultra Pure, Invitrogen) (top agar) in com-
plete growth media and plated in six-well plates pre-
coated with 2 ml of 0.8% L.M.P. agarose (base agar) in the
same medium. The cells were then overlaid with 2 ml of
complete growth media, which was changed every six
days. Three weeks after starting the culture, the colonies
were stained with 0.005% crystal violet in 25% methanol
and colonies were counted visually.
Three-dimensional culture
Three-dimensional cultivation of LNCaP cells was per-
formed, as described in [12]. To the wells of 24-well
plates, 200 μl of phenol red-free ice cold Matrigel were
added and the plates were placed in a 37°C incubator for
one hour to allow the matrix to gel. LNCaP cells were
seeded onto this bed as a single-cell suspension in a tissue-
culture medium containing 2% Matrigel. After Matrigel
polymerization at 37°C, the tissue-culture medium was
overlaid over polymerized Matrigel and the medium was
changed every 48 hours.
Results
Identifying mutant genes in prostate cancer cell lines using 
GINI analysis
In the original GINI protocol, the mRNA level alterations
detected by microarray hybridization after inhibition of
NMD in cells represent the result of two simultaneous
processes, i.e., mRNA synthesis and mRNA degradation.
The inability to distinguish between mRNA accumulation
caused by an induced novel mRNA synthesis and that
caused by blocking mRNA degradation is the major
source of false-positives produced by GINI analysis. Our
modified GINI protocol allows separation of these two
processes and analysis only mRNA degradation following
NMD inhibition. The protocol involves two consecutive
steps of NMD inhibition. In the first step, NMD is inhib-
ited in duplicate tissue-culture plates of each analyzed cell
line. During this step, the accumulation of mRNA tran-
scripts of stress-response genes due to enhanced transcrip-
tion as well as of genes representing a natural substrate of
NMD (including those containing nonsense mutations)
takes place. During the second step, transcription is
blocked with actinomycin D in both tissue-culture plates,
and NMD inhibition is continued in one tissue-culture
plate and released in the other for each analyzed cell line.
During this step, the natural substrate of NMD, including
nonsense mutation-containing transcripts, are degraded
at different rates between the two plates, depending on
the NMD status in each plate, while the stress response
genes should be degraded with the same efficiency regard-
less of NMD status, Comparing mRNA levels after the sec-
ond step of NMD inhibition using Affymetrix Genechip
hybridization allows measurement of the degree of mRNA
degradation when NMD is either "on" or "off", without
the interference of stress response-induced mRNA synthe-
sis. We applied this strategy to identify mutant genes in
the MSI -positive 22Rv1 and LNCaP prostate cancer cell
lines, also using these cell lines as controls against each
other, assuming that different genes were mutated in these
cell lines. To identify nonsense or frameshift mutation-
containing genes in LNCaP and 22Rv1 cells, we per-
formed the following microarray gene expression profil-
ing experiments: Using Affymetrix Plus2.0 Genechip
hybridization, we measured mRNA levels in LNCaP and
22Rv1 cells at the following times- 1) before inhibition of
NMD, 2) after inhibiting NMD for four4 hours by incu-
bating cells in a medium containing caffeine (We used caf-
feine instead of emetine for NMD inhibition because
NMD is quickly restored in the cells after removal of caf-
feine but not of emetine from the media [9].), 3) after fur-
ther inhibiting both NMD and transcription by
incubating cells in a medium containing both caffeine
and actinomycin D for four hours or after inhibiting tran-
scription only by incubating cells in the medium with
actinomycin D but without caffeine. Additional file 1:BMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
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Table S1 shows the quintile normalized log2 transformed
probe hybridization signal values of all performed micro-
array experiments.
To select candidates for sequencing out of a large list of
LNCaP genes cells showing mRNA alterations following
various modes of NMD inhibition, we applied the follow-
ing arbitrarily chosen cut-off thresholds to the quintile
normalized and log-transformed values of Affymetrix
Genechip hybridization signal intensities. First, the
mRNA level for a candidate gene in untreated cells before
NMD inhibition was more than four-fold lower (< -2 on
the log scale) in LNCaP cells than in 22Rv1 cells (assum-
ing that NMD degrades mutant mRNA transcript in
LNCaP cells). Second, the increases in mRNA levels fol-
lowing inhibition of NMD with caffeine in the first step
were more than threefold (>1.3 on the log scale) in
LNCaP cells and less than twofold (< 1.0 on the Log scale)
in 22Rv1 cells. And, finally, the mRNA level for a candi-
date gene in LNCaP cells after the second step of NMD
inhibition, i.e., after blocking both NMD and transcrip-
tion, was more than threefold higher than after blocking
transcription only, while in 22Rv1 cells the difference
after the second step was chosen to be less than two fold.
The candidates for the 22Rv1 cells were selected using the
same cut-off thresholds as for the LNCaP cells.
Analyzing the quintile normalized, log-transformed
Affymetrix hybridization data we identified 7 and 5
hybridization probes for the LNCap and 22Rv1 cells
respectively that satisfied the chosen cut-off thresholds
(Table 1). RT-PCR analysis (Figure 1A) shows that PARD3
and AS3 mRNA levels were lower in the LNCaP and in
22Rv1 cells respectively before NMD inhibition and were
up-regulated in these cells following NMD inhibition
with caffeine. By sequencing the cDNA corresponding to
the identified probes, we found mutations in the PARD3
and AS3 genes in the LNCaP and 22Rv1 cells respectively.
The homozygous frameshift mutation in another selected
candidate in the LNCaP cells, in the cleft lip and palate-
associated transmembrane protein 1 (CLPTM1), has been
identified previously [13]. Figure 1 shows that inactiva-
tion of the PARD3 and AS3 genes in the LNCaP and
22Rv1 cells occurred through two independent mutations
in both alleles of genes located in the regions of the cell
genome identified by aCGH analysis as LOH-free (Figure
1C). The inactivation of the CLPTM1 gene in LNCaP cells
on the other hand, most likely had occurred by mutation
in one allele and the loss of the other as suggested by the
gene's location in the region of LOH (Figure 1C). This
result illustrates that combining GINI and aCGH helps to
narrow down the number of candidates for sequencing
but may result in missing genes inactivated by two inde-
pendent mutations. It also shows the capability of the
Table 1: Candidates for sequencing analysis in the LNCaP and 22Rv1 selected using GINI.
GENE 
Symbol
Probe set ID 22Rv1 LNCaP
Log2 (signal) Log2 
Accumulation
Log2 
Degradation
Log2 (signal) Log2 
Accumulation
Log2 
Degradation
PARD3 221526_x_at 7.1 0.9 0.1 3.2 2.9 1.6
ANKRD28 213035_at 8.2 0.4 0.4 5.6 1.7 1.5
CLPTM1 211136_s_at 9.7 -0.5 -0.6 4.3 1.6 1.8
LNCaP 
candidate
VRK3 221999_at 6.5 0.3 0.5 3.9 1.5 2.5
s GTPBP2 221050_s_at 8.2 0.2 0.2 5.2 1.5 2.1
LOC692247 1561355_at 6.9 0.1 0.3 3.9 1.5 1.5
AFF1 227198_at 10.5 -0.6 0.7 5.4 1.3 1.4
AS3 207956_x_at 5.9 2.6 1.4 10.0 0.1 0.3
22RV1 TTLL7 219882_at 3.6 2.0 1.4 7.6 0.3 0.9
candidate PDSB5 204742_s_at 3.9 1.9 1.3 7.8 -0.6 -0.6
s EIF5 208708_x_at 9.2 1.7 2.5 11.3 0.7 0.9
EIF2C2 225827_at 3.5 1.6 1.9 6.1 -0.6 0.1
RNAs from LNCaP and 22Rv1 cells were analyzed using Afffymetrix GeneChip Human Genome U133Plus 2.0 Array hybridization after the following 
treatments: 1) no treatment, 2) incubation with caffeine for four hours, 3) incubation with caffeine and actinomicin D following caffeine treatment for 
four hours and 4) incubation with actinomycin D following caffeine treatment for four hours. The candidates for sequencing analysis for LNCaP cells 
were selected by sorting the normalized, Log2 transformed hybridization signal values data using the following criteria: 1) expression of the candidate 
gene in the untreated LNCaP cells is more than four-times lower than in the untreated 22Rv1 cells used as a control, i.e., Log2(signal LNCaP) - 
Log2(signal 22Rv1) <2.0; 2). The mRNA level accumulation for candidate genes following incubation with caffeine for four hours should be more than 
threefold and less than twofold in the LNCaP and 22Rv1 cells, respectively: i.e., Log2 (Accumulation LNCaP) >1.3 and Log2(Accumulation 22Rv1) 
<1.0; 3). The mRNA levels for candidates after inhibiting both mRNA synthesis and mRNA degradation with actinomycin D and caffeine should be 
more than threefold and less than twofold higher than after inhibiting mRNA synthesis only with actinomycin D for the LNCaP and 22Rv1 cells, 
respectively: i.e., Log2 (Degradation LNCaP) >1.3 and Log2 (Degradation22Rv1) <1.0. Candidates for the 22Rv1 cells were selected in the same way, 
using the LNCaP cell as a control. Five probes for the 22Rv1 and seven probes for the LNCaP cells satisfied the described selection criteria.BMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
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Heterozygous bi-allelic inactivating mutations in PARD3 and AS3 genes in the LOH -free regions in LNCaP cells Figure 1
Heterozygous bi-allelic inactivating mutations in PARD3 and AS3 genes in the LOH -free regions in LNCaP 
cells. (A). RT-PCR analysis shows the lower mRNA levels in the untreated and the increased levels in caffeine treated LNCaP 
and 22Rv1 cells for the PARD3 and for AS3 genes, respectively. (B). Sequencing chromatograms show heterozygous deletion 
of a T in the (T)5 coding repeat in one allele and C to T substitution resulting in the TAA stop codon in the other allele of the 
PARD3 gene in LNCaP cells (top); heterozygous deletion of a C in the (C)7 repeat in one allele and of an A in the (A)9 repeat 
in the other allele of the AS3 gene in the 22Rv1 cells (middle); and a homozygous deletion of a C in the (C)2 repeat of the 
CLPTM1 gene in the LNCaP cells (bottom). (B). Array CGH analysis shows normal genomic content in the PARD3 and AS3 
loci in the LNCaP and 22Rv1 cells and the loss of heterozygosity for the CLPTM1 locus in LNCaP cells.BMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
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GINI to efficiently identify mutant genes regardless of the
information on LOH.
Mutations in the AS3 gene in 22Rv1 cells are likely to occur 
during the growth of the primary tumor
The androgen-induced AS3 gene, also known as regulator
of cohesion maintenance, homolog B (S. cerevisiae)
(PDSB5), has been shown to be a mediator of the andro-
gen-induced proliferative arrest of human androgen sensi-
tive prostate cells in culture and in the rat prostate in situ
[14]. 22Rv1 cells containing two heterozygous inactivat-
ing frameshift mutations in the AS3 gene is a human pros-
tate carcinoma epithelial cell line derived from a xenograft
that was serially propagated in mice after castration-
induced regression and relapse of the parental, androgen-
dependent CWR22 xenograft [15]. We rationalized that
mutations in the AS3 gene could be selected during prop-
agation of CWR22 cells in castrated mice and thus might
account for the tumor relapse in castrated mice, giving rise
to the 22Rv1 variant. Sequencing of the CWR22 genomic
DNA, however, has identified AS3 gene mutations identi-
cal to that in 22Rv1 (not shown), suggesting that muta-
tions in the AS3 gene occurred during the growth of the
original primary tumor and not during the propagation of
CWR22 cells in castrated animals or the passaging of
22Rv1 cells in tissue culture. This result is in line with pre-
viously reported findings [7] demonstrating that each of
the mutations detected in the 22Rv1 prostate cancer cell
line was also detected in the CWR22 cells.
Analysis of phenotype alterations produced by expression 
of the PARD3 gene in LNCaP cells
The product of the PARD3 gene, which was first identified
in C. elegans, is essential for asymmetric cell division and
polarized growth. The protein has been reported to be
involved in epithelial tight junction [16] and in cell-cell
adherence junction [17]. To analyze the role of muta-
tional inactivation the PARD3 gene for the LNCaP cells,
we cloned the cDNA corresponding to the NM_019619.2
transcript variant of the RARD3 mRNA with the sequence
of FLAG-tag attached to the 3' end into the pBMN-I-GFP
retroviral expression vector. The FLAG-tagged PARD3
expression vector or empty vector (EGFP), was used for
virus production and transfection of LNCaP cells. Western
blot analysis with anti-FLAG or with anti-Par3 antibodies
shows a protein band of predicted size in the LNCaP cells
tranfected with the PARD3-Flag expression construct but
not in control LNCaP cell not transfected with the con-
struct or transfected with the empty EGFP vector (Figure
2A). Immunofluorescence analysis with anti-Flag anti-
bodies has shown localization of the ectopically expressed
Par3 protein along cell-cell contact regions (Figure 2B), in
agreement with the reported involvement of Par3 protein
in an epithelial tight junctions [16] and in an adherens
junctions [18].
Examination with a light microscope did not detect signif-
icant differences in appearance between the LNCaP cells,
ectopically expressing Par3 protein, and the LNCaP cells
transfected with empty vector (Figure 3A). However, since
slight alterations in cell shape still could be observed
(Par3 expressing cells seem to look slightly more attached
to the plastic) we investigated the results of ectopic Par3
expression on focal adhesion as well as on tight and on
adherens junctions. Staining of control and Par3 express-
ing LNCaP cells with anti-vinculin antibodies has shown
that focal adhesions was not affected by ectopic expres-
sion of Par3 (Figure 3B top). Neither had Par3 expression
had an effect on adherens junction as shown by staining
with anti E-cadherin antibody (Figure 3B middle). How-
ever, staining with anti-ZO-1 (used as a marker for tight
junction) antibody has shown that tight junction might
be affected by ectopic Par3 expression. Usually, the ZO-1
staining surrounds cells by continuous line when their
tight junctions are well established. On the contrary,
LNCaP cells are traced by ZO-1 staining with dots as a
clear indication of not so well established tight junctions
(Figure 3B EGFP bottom). The expression of Par3
increases partially the continuality of the ZO-1 signal
which indicates some stabilization (but not restoring) of
tight junctions (Figure 3B bottom).
We also found that expression of Par3 resulted in higher
adhesion of LNCaP cells to the components of extracellu-
lar matrix collagen type I and fibronectin (Figure 4).
Contrary to our expectations, with regard to a possible
tumor-suppressor role for the PARD3 gene, ectopic
expression of the PARD3 gene in LNCaP cells resulted in
a higher proliferation rate in tissue-culture (Figure 3C).
On the other hand, anchorage independent growth in soft
agar was inhibited by PARD3 expression. Figure 5A illus-
trates that although number of colonies with diameter
>0.2 mm formed by PARD3-expressing cells was slightly
higher than that formed by control LNCaP cells tranfected
with empty vector, the number of larger colonies with
diameter >0.5 mm was significantly lower in the PARD3-
expressing cells (Figure 5B). Also we found that expres-
sion of PARD3 affected the growth of LNCaP cells in 3D
culture in Matrigel. Figure 5C shows that colonies formed
by LNCaP cells not expressing Par3 protein are larger and
look more condensed, while the colonies formed by Par3
expressing cells look dispersed at the periphery.
Discussion
We have previously demonstrated using GINI that LNCaP
cells have biallelic inactivating mutations in the JAK1,
CLPTM1 and SYNJ2 genes [13]. In this work, using an
improved version of GINI, we have added the PARD3 to
the list of mutant genes in the LNCaP cells. Our method
has again identified the CLPTM1 as a candidate for
sequencing but missed the JAK1 and SYNJ2 genes. TheBMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
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reason we missed the SYNJ2 may be that the cut- off
threshold chosen for selecting candidates for sequencing
were too stringent. Analyzing the microarray data in the
Additional file 1: Table S1, one can see that loosing the
stringency of selection parameters results in the appear-
ance of the SYNJ2 gene in the list of candidates; however,
the list is becoming too large. The JAK1 gene was missed
because the 22Rv1 cells used as a control for the LNCaP
also contained a mutation in the JAK1. Using an addi-
tional control cell line, such as PC3, for example, would
result in including the JAK1 in the list of candidates, since
PC3 has no mutation in this gene. The advantage of using
many cell lines in GINI analysis has been demonstrated
recently by identifying mutations in melanoma cell lines
[19]. By analyzing a panel of 12 cell lines, the authors
identified three novel melanoma tumor-suppressor genes.
The melanoma cell lines analyzed do not have microsatel-
lite instability and, consequently, must have low muta-
tion frequency. This fact, besides suggesting the
importance of mutant genes for the development of
melanoma, demonstrates that GINI is not restrained to
identifying mutations in MSI positive cell lines. Although
applying our version of GINI to simultaneous analysis of
multiple cell lines of the same tumor type could dramati-
cally improve the efficiency of mutation identifications,
false positives caused by cell line-specific variability in the
efficiency of NMD degradation of transcripts representing
the natural substrate of NMD put limit on GINI efficiency.
Another limitation to GINI efficiency is the reported vari-
ability in the efficiency of NMD for the degradation of
mutant mRNAs [20]. Finally, short-lived mRNAs tran-
scripts degraded by other than NMD mechanisms will
also be frequently overlooked in GINI analysis. With the
advent of the next-generation sequencing, however, fur-
ther improvement of GINI efficiency may become irrele-
vant.
The AS3 gene in the 22RV1 cells has been inactivated by
frameshift mutations in the (C)7 and (A)9 mononucle-
otide repeats. Frameshift mutations at repetitive
sequences in a coding DNA in cancers with MSI do not
necessary indicate the tumor-suppressor role of the
mutant genes, but may be just a byproduct of the inherent
instability of repetitive DNA. However, the involvement
of the AS3 gene product into androgen receptor signaling
and vitamin D receptor action in prostate cancer cells [21]
suggests that inactivation of AS3 may contribute to the
development of androgen-independent prostate cancer.
Ectopic expression of Par3 protein in the LNCaP cells Figure 2
Ectopic expression of Par3 protein in the LNCaP cells. (A). Western blotting with anti-Flag (left) or with anti-PARD3 
(right) antibody shows PARD3 expression in whole-cell lysates from the LNCaP cells stably transfected with Flag-tagged 
PARD3 expression vector but not in control nontransfected cells or transfected with EGFP empty vector. Blotting with anti-β-
actin antibody was used as a loading control. (B) Immunofluorescent analysis with anti-flag antibodies shows localization of 
exogenous Flag-tagged Par3 protein at cell-cell contacts. Size bar is 20 μm.BMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
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The type of mutations in the PARD3 gene in LNCaP cells,
a base substitution resulting in nonsense codon in one
allele and the deletion of a (T) in a (T)5 repeat in the other
allele, suggests the selective advantage provided by the
mutational inactivation of the gene; a repeat as short as
(T)5 is stable even in cancers with MSI [22,23] and two
independent mutations in a gene is a highly improbable
event to occur without selection. The higher proliferation
rate of LNCaP cells following the ectopic expression of
PARD3 gene indicates that the mutations were unlikely to
occur during the propagation of LNCaP cells in tissue cul-
ture; the LNCaP cells without mutations in the PARD3
gene would quickly outgrow the cells with mutations in
tissue culture.
Par3 protein is a member of the Par complex that includes
Par3, Par6, serine/threonine kinase aPKC (atypical Pro-
tein Kinase C) and small GTPase Cdc42 [24-26]. The com-
plex regulates epithelial cell-polarity and asymmetric cell
division. Loss of cell polarity is thought to be involved in
multiple aspects of oncogenesis, such as invasive and
migratory processes [27,28], it is also suggested that
deregulation of asymmetric cell divisions of stem or pro-
genitor cells could be responsible for the abnormal self-
Effect of Par3 protein expression on cell morphology, focal adhesion contacts, cell-cell contacts and proliferation rate Figure 3
Effect of Par3 protein expression on cell morphology, focal adhesion contacts, cell-cell contacts and prolifera-
tion rate. (A). Phase contrast images (200×) of the LNCaP cells expressing or not expressing Par3 protein. (B). Immunoflures-
cent images showing the foci of vinculin (vin) - representative marker for focal adhesion contacts (stained with red indicated 
with arrows), E-cadherin - (E-cad) representative marker for adherens junctions (stained with red). Zonula occludens-1 (ZO-1) 
- representative marker for tight junctions is presented with overlay pictures from three independent layers: Differential Inter-
ference Contrast (DIC) visualizing cells shape, ZO-1 stained with red (indicated with arrows) and nuclei stained with blue. Size 
bar is 20 μm. (C). 5 × 103 cells per well were seeded in 24-well format tissue culture plate in RPMI 1640 containing 5% fetal calf 
serum (FBS). Cells were cultured for indicated time periods, harvested and counted by hemocytometer. Cell numbers are 
shown as the average ± S.D. of counting of cells in four wells per time-point. The experiment was repeated independently 
three times with similar results.BMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
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renewal and differentiation of cancer stem cells [29,30].
Although restoration of PARD3 expression in LNCaP cells
resulted in a higher rate of cell-proliferation in tissue cul-
ture, it also impaired the ability to form large, condensed
colonies in a three-dimensional culture. This fact supports
the idea that cell-polarity-mediated 3D tissue organiza-
tion can function as a non-canonical tumor-suppressor
[30]. Since the restoration of PARD3 expression in LNCaP
cells did not suppress tumor growth in subcutaneously
injected nude mice (data not shown) we can suggest that
mutational inactivation of the PARD3 gene could be a
tumor-initiating event and occur at the level of the pros-
tate stem cell. PARD3 inactivation-mediated loss of asym-
metric cell division could lead to accumulation of stem or
progenitor cells and to disruption of 3D tissue organiza-
tion, resulting in the initiation of tumor formation. Alter-
natively, PARD3 inactivation could be a late event in the
LNCaP tumor progression. Since the expression of Par3
protein resulted in a higher adhesiveness of LNCaP cells to
the components of the extracellular matrix, it is possible
that the PARD3 inactivation, although reducing the prolif-
erative potential at the same time promoted cell migration
to the lymph node, from which the LNCaP cell line is
derived.
Conclusion
Using an improved version of GINI, we identified biallelic
inactivating mutations in the AS3 and PARD3 genes in
Ectopic expression of Par3 protein enhances adhesiveness of the LNCaP cells Figure 4
Ectopic expression of Par3 protein enhances adhesiveness of the LNCaP cells. (A). 2 × 104 of LNCaP cells stably 
expressing Par3 protein or transfected with empty vector (EGFP) were seeded over fibronectin or collagen Type I pre-coated 
wells of a 96-well plate and incubated at 37°C for three hours, as described in the "Methods" section. After washing the wells 
with Dulbecco's phosphate-buffered saline the numbers of attached cells were calculated as the average from eight wells. The 
results were presented as the mean value ± S.D. The experiment was repeated three times with similar results. (B). Represent-
ative phase-contrast pictures (200×) of the cells attached to wells coated with fibronectin (FN) and collagen Type I (Col) after 
performing adhesion assay as described above for panel (A).BMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
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prostate cancer cell lines. Inactivation in a prostate cancer
cell line of the PARD3 gene, involved in asymmetric cell
division and maintenance of cell-polarity suggests that the
loss of cell-polarity contributes to prostate carcinogenesis.
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Effect of expression of Par3 protein on anchorage-independent growth and on three-dimensional growth in Matrigel matrix Figure 5
Effect of expression of Par3 protein on anchorage-independent growth and on three-dimensional growth in 
Matrigel matrix. (A). Representative images of the wells with colonies developed inside soft agar on day 21. (B). Charts rep-
resents the actual number of colonies per well with cut off diameter for counting - 0.2 mm and 0.5 mm. The experiment is rep-
resentative of three independent analyses with similar results. (C). The effect of PARD3 expression on the three-dimensional 
growth of LNCaP cells in reconstituted basement membrane (Matrigel). Equal numbers of LNCaP cells expressing Par3 protein 
or control LNCaP cells transfected with empty vector (EGFP) were seeded over Matrigel pre-coated wells of 24-well plate 
plates in 2% Matrigel as described in "Methods". The phase contrast images (200×) were taken on every 4 days to track 3D 
structure formation. The images represent three independent experiments with similar results.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cancer 2009, 9:318 http://www.biomedcentral.com/1471-2407/9/318
Page 12 of 12
(page number not for citation purposes)
Acknowledgements
This work was supported by National Cancer Institute grant 
R01CA109256 and by Department of Defense grant W81XWH-04-1-
0045.
References
1. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE: Nonsense-
mediated decay approaches the clinic.  Nat Genet 2004,
36(8):801-808.
2. Maquat LE: Nonsense-mediated mRNA decay: splicing, trans-
lation and mRNP dynamics.  Nat Rev Mol Cell Biol 2004,
5(2):89-99.
3. Ishigaki Y, Li X, Serin G, Maquat LE: Evidence for a pioneer round
of mRNA translation: mRNAs subject to nonsense-mediated
decay in mammalian cells are bound by CBP80 and CBP20.
Cell 2001, 106(5):607-617.
4. Noensie EN, Dietz HC: A strategy for disease gene identifica-
tion through nonsense-mediated mRNA decay inhibition.
Nat Biotechnol 2001, 19(5):434-439.
5. Mendell JT, Sharifi NA, Meyers JL, Martinez-Murillo F, Dietz HC:
Nonsense surveillance regulates expression of diverse
classes of mammalian transcripts and mutes genomic noise.
Nat Genet 2004, 36(10):1073-1078.
6. Huusko P, Ponciano-Jackson D, Wolf M, Kiefer JA, Azorsa DO, Tuz-
men S, Weaver D, Robbins C, Moses T, Allinen M, et al.: Nonsense-
mediated decay microarray analysis identifies mutations of
EPHB2 in human prostate cancer.  Nat Genet 2004,
36(9):979-983.
7. Sun X, Chen C, Vessella RL, Dong JT: Microsatellite instability
and mismatch repair target gene mutations in cell lines and
xenografts of prostate cancer.  Prostate 2006, 66(6):660-666.
8. Thibodeau SN, Bren G, Schaid D: Microsatellite instability in can-
cer of the proximal colon.  Science 1993, 260(5109):816-819.
9. Ivanov I, Lo KC, Hawthorn L, Cowell JK, Ionov Y: Identifying can-
didate colon cancer tumor suppressor genes using inhibition
of nonsense-mediated mRNA decay in colon cancer cells.
Oncogene 2007, 26(20):2873-2884.
10. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ,
Scherf U, Speed TP: Exploration, normalization, and summa-
ries of high density oligonucleotide array probe level data.
Biostatistics 2003, 4(2):249-264.
11. Cowell JK, Matsui S, Wang YD, LaDuca J, Conroy J, McQuaid D,
Nowak NJ: Application of bacterial artificial chromosome
array-based comparative genomic hybridization and spec-
tral karyotyping to the analysis of glioblastoma multiforme.
Cancer Genet Cytogenet 2004, 151(1):36-51.
12. Debnath J, Muthuswamy SK, Brugge JS: Morphogenesis and onco-
genesis of MCF-10A mammary epithelial acini grown in
three-dimensional basement membrane cultures.  Methods
2003, 30(3):256-268.
13. Rossi MR, Hawthorn L, Platt J, Burkhardt T, Cowell JK, Ionov Y: Iden-
tification of inactivating mutations in the JAK1, SYNJ2, and
CLPTM1 genes in prostate cancer cells using inhibition of
nonsense-mediated decay and microarray analysis.  Cancer
Genet Cytogenet 2005, 161(2):97-103.
14. Maffini MV, Geck P, Powell CE, Sonnenschein C, Soto AM: Mecha-
nism of androgen action on cell proliferation: AS3 protein as
a mediator of proliferative arrest in the rat prostate.  Endo-
crinology 2002, 143(7):2708-2714.
15. Sramkoski RM, Pretlow TG 2nd, Giaconia JM, Pretlow TP, Schwartz
S, Sy MS, Marengo SR, Rhim JS, Zhang D, Jacobberger JW: A new
human prostate carcinoma cell line, 22Rv1.  In Vitro Cell Dev Biol
Anim 1999, 35(7):403-409.
16. Wang Y, Du D, Fang L, Yang G, Zhang C, Zeng R, Ullrich A, Lotts-
peich F, Chen Z: Tyrosine phosphorylated Par3 regulates epi-
thelial tight junction assembly promoted by EGFR signaling.
Embo J 2006, 25(21):5058-5070.
17. Manabe N, Hirai S, Imai F, Nakanishi H, Takai Y, Ohno S: Associa-
tion of ASIP/mPAR-3 with adherens junctions of mouse neu-
roepithelial cells.  Dev Dyn 2002, 225(1):61-69.
18. Iden S, Rehder D, August B, Suzuki A, Wolburg-Buchholz K, Wolburg
H, Ohno S, Behrens J, Vestweber D, Ebnet K: A distinct PAR com-
plex associates physically with VE-cadherin in vertebrate
endothelial cells.  EMBO Rep 2006, 7(12):1239-1246.
19. Bloethner S, Mould A, Stark M, Hayward NK: Identification of
ARHGEF17, DENND2D, FGFR3, and RB1 mutations in
melanoma by inhibition of nonsense-mediated mRNA
decay.  Genes Chromosomes Cancer 2008, 47(12):1076-1085.
20. El-Bchiri J, Buhard O, Penard-Lacronique V, Thomas G, Hamelin R,
Duval A: Differential nonsense mediated decay of mutated
mRNAs in mismatch repair deficient colorectal cancers.
Hum Mol Genet 2005, 14(16):2435-2442.
21. Murthy S, Agoulnik IU, Weigel NL: Androgen receptor signaling
and vitamin D receptor action in prostate cancer cells.  Pros-
tate 2005, 64(4):362-372.
22. Suzuki K, Dai T, Suzuki I, Dai Y, Yamashita K, Perucho M: Low muta-
tion incidence in polymorphic noncoding short mononucle-
otide repeats in gastrointestinal cancer of the microsatellite
mutator phenotype pathway.  Cancer Res 2002,
62(7):1961-1965.
23. Woerner SM, Benner A, Sutter C, Schiller M, Yuan YP, Keller G, Bork
P, Doeberitz MK, Gebert JF: Pathogenesis of DNA repair-defi-
cient cancers: a statistical meta-analysis of putative Real
Common Target genes.  Oncogene 2003, 22(15):2226-2235.
24. Joberty G, Petersen C, Gao L, Macara IG: The cell-polarity protein
Par6 links Par3 and atypical protein kinase C to Cdc42.  Nat
Cell Biol 2000, 2(8):531-539.
25. Johnson DI: Cdc42: An essential Rho-type GTPase controlling
eukaryotic cell polarity.  Microbiol Mol Biol Rev 1999, 63(1):54-105.
26. Lin D, Edwards AS, Fawcett JP, Mbamalu G, Scott JD, Pawson T: A
mammalian PAR-3-PAR-6 complex implicated in Cdc42/
Rac1 and aPKC signalling and cell polarity.  Nat Cell Biol 2000,
2(8):540-547.
27. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams
ED, Thompson EW: Epithelial--mesenchymal and mesenchy-
mal--epithelial transitions in carcinoma progression.  J Cell
Physiol 2007, 213(2):374-383.
28. Moreno-Bueno G, Portillo F, Cano A: Transcriptional regulation
of cell polarity in EMT and cancer.  Oncogene 2008,
27(55):6958-6969.
29. Aranda V, Nolan ME, Muthuswamy SK: Par complex in cancer: a
regulator of normal cell polarity joins the dark side.  Oncogene
2008, 27(55):6878-6887.
30. Lee M, Vasioukhin V: Cell polarity and cancer--cell and tissue
polarity as a non-canonical tumor suppressor.  J Cell Sci 2008,
121(Pt 8):1141-1150.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2407/9/318/pre
pub